All News about Immunome Inc
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](/next-assets/images/schema-image-default.png)
Immunome: Q1 Earnings Insights
May 05, 2023
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Immunome, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Immunome, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/01/06/imnm_logo_light__02fb62896471c35cf6349c19efc96e62.png?width=1200&height=800&fit=crop)
Immunome Stock Jumps On Discovery Pact With AbbVie
January 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/07/06/aapharma_1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/short_image_34.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Immunome, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.investors.com/wp-content/uploads/2022/04/Stock-abbvie-04-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/06/image-jobs.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/05/19/aapharma_14.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_6442.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/06/image_4.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Reports Third Quarter 2022 Financial Results
November 14, 2022
From Immunome, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/11/30/image49.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_400.png?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Reports Second Quarter 2022 Financial Results
August 05, 2022
From Immunome, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/07/01/image11.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Immunome, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/05/19/stock-market-6693060.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/19/mid-day_movers_image.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/20/yesterdays_movers.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.